MoonLake Immunotherapeutics

EMA and FDA green-light MoonLake to advance IL-17 inhibitor
Clinical Trials Arena
Wed, 02/28/24 - 09:38 pm
MoonLake Immunotherapeutics
sonelokimab
FDA
EMA
hidradenitis suppurativa
MoonLake Looks to Raise $250M in Stock Offering on Heels of Mid-Stage Data
BioSpace
Tue, 06/27/23 - 11:35 am
MoonLake Immunotherapeutics
sonelokimab
hidradenitis suppurativa
Spotlight – following Humira in hidradenitis suppurativa
EP Vantage
Tue, 04/4/23 - 10:10 am
AbbVie
Humira
hidradenitis suppurativa
UCB Pharma
Bimzelx
MoonLake Immunotherapeutics
MoonLake launches, licensing in Merck KGaA’s Cosentyx challenger sonelokimab
Pharmaforum
Tue, 05/4/21 - 10:37 am
MoonLake Immunotherapeutics
sonelokimab
Merck KGaA
inflammatory disease